retatrutide eli lilly phase 2 results just announced striking 3 for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Drug retatrutide helps people lower

This means that half the drug concentration leaves the bloodstream every 120 hours

Eventually, the FDA approved GLP-1 drugs specifically for it, Dr

In addition to weight loss, Wegovy is FDA-approved to reduce the risk of major adverse cardiovascular events like heart attack and stroke in obese or overweight adults with heart disease

Patients with alcohol use disorder may have unique safety considerations when using GLP-1 medications

Recent data show that GLP-1 prescriptions for weight loss have surged, with usage increasing nearly 587 % between 2019 and 2024 , reflecting strong ongoing GLP-1 demand in the U.S

Before your shipment leaves China, verify that every document is present, consistent, and accurate